Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase

Gastric cancer (GC) is one of the most common cancers worldwide. In the clinical setting, the identification of HER2 overexpression in GC was a significant finding, as trastuzumab, an anti-HER2 drug, provides a survival advantage to HER2-positive GC patients. In HER2-postive GC, the dysregulation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokumaru, Yoshihisa, Tajirika, Toshihiro, Sugito, Nobuhiko, Kuranaga, Yuki, Shinohara, Haruka, Tsujino, Takuya, Matsuhashi, Nobuhisa, Futamura, Manabu, Akao, Yukihiro, Yoshida, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479539/
https://www.ncbi.nlm.nih.gov/pubmed/30959742
http://dx.doi.org/10.3390/ijms20071697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479539/
https://www.ncbi.nlm.nih.gov/pubmed/30959742
http://dx.doi.org/10.3390/ijms20071697

Ejemplares similares